Life Sciences Industry Hampered by Slow Digital Progress
June 29, 2015.
A new study by assessing the "overall digital maturity" of life sciences companies reveals that they are "not maturing fast enough". Across Health's Multichannel Maturometer suggests that a lack of a strong vision and strategy is to blame; only one in four respondents said they felt their company had a digital strategy. Only 13% of the survey's respondents were satisfied to very satisfied with their digital initiatives, with 42% not satisfied and 40% not sure. Dissatisfaction has thus dropped to 2010-2011 levels. According to Across Health, the top bottlenecks include regulatory issues, no clear digital strategy and not enough internal knowledge. For more information on the study results, click here.
Is Artificial Intelligence a ‘Product’? Products Liability Implications for AI-Based Products
April 10th 2025As the physical products we use evolve to become increasingly complex, traditional products liability frameworks may not always fit to provide remedies for harm that can result from using novel product types.
